Profound Medical Corp. (PROF) Tops Q1 EPS by 7c

Profound Medical Corp. (NASDAQ: PROF) reported Q1 EPS of ($0.19), $0.07 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $5.04 million.

GUIDANCE:

Profound Medical Corp. sees FY2026 revenue of $25 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• Kadima sues NRx Pharmaceuticals over failed acquisition deal
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat